The global real-time PCR, digital PCR, and end-point PCR market size is expected to reach USD 7.18 billion by 2030, registering a CAGR of 4.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Gather more insights about the market drivers, restrains and growth of the Real-Time Pcr & Digital Pcr Market
Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights
• By technology, the Quantitative PCR segment held largest revenue share of over 83.34% in 2023. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
• The consumables and reagents segment held the largest revenue share of over 62.62% in 2023 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
• North America dominated the market with a revenue share of over 35.94% in 2023 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
• The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is projected to grow at a CAGR of 6.6% from 2025 to 2030.
• The global genetic testing market size was estimated at USD 11.71 billion in 2024 and is projected to grow at a CAGR of 22.5% from 2025 to 2030.
Real-time PCR, Digital PCR, And End-point PCR Market Segmentation
Grand View Research has segmented the global real-time PCR, digital PCR, and end-point PCR market based on products, technology, application, and region:
Real-time PCR, Digital PCR, And End-point PCR Technology Outlook (Revenue, USD Million, 2018 - 2030)
• Quantitative
o Consumables & Reagents
o Instruments
o Software & Services
• Digital
o Consumables & Reagents
o Instruments
o Software & Services
• End-point
o Consumables & Reagents
o Instruments
o Software & Services
Real-time PCR, Digital PCR, And End-point PCR Product Outlook (Revenue, USD Million, 2018 - 2030)
• Consumables & Reagents
• Instruments
• Software & Services
Real-time PCR, Digital PCR, And End-point PCR Application Outlook (Revenue, USD Million, 2018 - 2030)
• Clinical
o Pathogen Testing
o Oncology testing
o Blood Screening
o Liquid Biopsy
o dPCR-based Non-Invasive Prenatal Testing (NIPT)
o Others
• Research
o Stem Cell Research
o DNA Cloning & Sequencing
o Recombinant DNA Technology
o Rare Mutation Detection
o Gene Expression
o Single Cell Analysis
o Microbiome Analysis
o Copy Number Variation Analysis
o Library Quantification (NGS)
o Characterization of Low-fold Changes in mRNA and miRNAExpression"
o Species Identification
o GMO Detection
• Forensic
Real-time PCR, Digital PCR, And End-point PCR Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwai
Order a free sample PDF of the Real-Time Pcr & Digital Pcr Market Intelligence Study, published by Grand View Research.
